Morphological changes produced by drugs acting on the autonomic nervous system.
D015115:5,6-Dihydroxytryptamine / Q000633:toxicity; D015116:5,7-Dihydroxytryptamine / Q000633:toxicity; D000818:Animals; D000959:Antihypertensive Agents / Q000633:toxicity; D001341:Autonomic Nervous System / Q000187:drug effects* / Q000473:pathology; D001949:Bretylium Compounds / Q000633:toxicity; D003647:Debrisoquin / Q000633:toxicity; D006145:Guanethidine / Q000633:toxicity; D006146:Guanidines / Q000633:toxicity; D006892:Hydroxydopamines / Q000633:toxicity; D009422:Nervous System Diseases / Q000139:chemically induced* / Q000473:pathology; D010847:Picolines / Q000633:toxicity; D012110:Reserpine / Q000633:toxicity
D000959:Antihypertensive Agents; D001949:Bretylium Compounds; D006146:Guanidines; D006892:Hydroxydopamines; D010847:Picolines; D015116:5,7-Dihydroxytryptamine; D012110:Reserpine; D015115:5,6-Dihydroxytryptamine; D003647:Debrisoquin; D006145:Guanethidine